Evolutionary Genomics FNAM Stock
Evolutionary Genomics Price Chart
Evolutionary Genomics FNAM Financial and Trading Overview
| Evolutionary Genomics stock price | 0.45 USD |
| Previous Close | 0.65 USD |
| Open | 0.65 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.65 - 0.65 USD |
| 52 Week Range | 0.6 - 0.72 USD |
| Volume | 1.02K USD |
| Avg. Volume | 344 USD |
| Market Cap | 4.33M USD |
| Beta (5Y Monthly) | -0.176056 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.35 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
FNAM Valuation Measures
| Enterprise Value | 13.35M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -13.448 |
Trading Information
Evolutionary Genomics Stock Price History
| Beta (5Y Monthly) | -0.176056 |
| 52-Week Change | -7.14% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.72 USD |
| 52 Week Low | 0.6 USD |
| 50-Day Moving Average | 0.66 USD |
| 200-Day Moving Average | 0.69 USD |
FNAM Share Statistics
| Avg. Volume (3 month) | 344 USD |
| Avg. Daily Volume (10-Days) | 0 USD |
| Shares Outstanding | 6.66M |
| Float | 4.48M |
| Short Ratio | N/A |
| % Held by Insiders | 32.65% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 16:1000 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -47.63% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -992809 USD |
| Net Income Avi to Common (ttm) | -2248260 USD |
| Diluted EPS (ttm) | -0.35 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 577.07K USD |
| Total Cash Per Share (mrq) | 0.09 USD |
| Total Debt (mrq) | 3.74M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 3.921 |
| Book Value Per Share (mrq) | -1.116 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -640947 USD |
| Levered Free Cash Flow (ttm) | 35.08K USD |
Profile of Evolutionary Genomics
| Country | United States |
| State | CO |
| City | Castle Rock |
| Address | 4220 Morning Star Drive |
| ZIP | 80108 |
| Phone | 720 900 8666 |
| Website | https://www.evolgen.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 2 |
Evolutionary Genomics, Inc., together with its subsidiaries, engages in the research and identification of positively selected genes in humans, animals, and commercial crops. The company develops Adapted Traits Platform, a technology platform to identify genes for enhancing crop plant traits, such as yield, sugar content, biomass, drought tolerance, and pest/disease resistance. It serves governmental organizations, non-profit foundations, and commercial entities. The company is based in Castle Rock, Colorado.
Q&A For Evolutionary Genomics Stock
What is a current FNAM stock price?
Evolutionary Genomics FNAM stock price today per share is 0.45 USD.
How to purchase Evolutionary Genomics stock?
You can buy FNAM shares on the Other OTC exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Evolutionary Genomics?
The stock symbol or ticker of Evolutionary Genomics is FNAM.
Which industry does the Evolutionary Genomics company belong to?
The Evolutionary Genomics industry is Biotechnology.
How many shares does Evolutionary Genomics have in circulation?
The max supply of Evolutionary Genomics shares is 6.66M.
What is Evolutionary Genomics Price to Earnings Ratio (PE Ratio)?
Evolutionary Genomics PE Ratio is now.
What was Evolutionary Genomics earnings per share over the trailing 12 months (TTM)?
Evolutionary Genomics EPS is -0.35 USD over the trailing 12 months.
Which sector does the Evolutionary Genomics company belong to?
The Evolutionary Genomics sector is Healthcare.